Photon Co., Ltd.

KOSDAQ:A208710 Stock Report

Market Cap: ₩24.1b

Photon Balance Sheet Health

Financial Health criteria checks 6/6

Photon has a total shareholder equity of ₩48.8B and total debt of ₩18.5B, which brings its debt-to-equity ratio to 37.9%. Its total assets and total liabilities are ₩90.6B and ₩41.8B respectively. Photon's EBIT is ₩1.1B making its interest coverage ratio 2. It has cash and short-term investments of ₩8.8B.

Key information

37.86%

Debt to equity ratio

₩18.49b

Debt

Interest coverage ratio2x
Cash₩8.81b
Equity₩48.84b
Total liabilities₩41.78b
Total assets₩90.61b

Recent financial health updates

Recent updates

Analysis Article Jan 16

We Think Photon (KOSDAQ:208710) Has A Fair Chunk Of Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Nov 14

Little Excitement Around Photon Co., Ltd.'s (KOSDAQ:208710) Revenues As Shares Take 26% Pounding

The Photon Co., Ltd. ( KOSDAQ:208710 ) share price has softened a substantial 26% over the previous 30 days, handing...
Analysis Article Sep 26

Optimistic Investors Push Photon Co., Ltd. (KOSDAQ:208710) Shares Up 25% But Growth Is Lacking

Photon Co., Ltd. ( KOSDAQ:208710 ) shareholders would be excited to see that the share price has had a great month...
Analysis Article May 20

It's A Story Of Risk Vs Reward With Photon Co., Ltd. (KOSDAQ:208710)

With a median price-to-sales (or "P/S") ratio of close to 0.7x in the Electronic industry in Korea, you could be...
Analysis Article Mar 20

Does Biolog Device (KOSDAQ:208710) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article Jan 03

Further Upside For Biolog Device Co., Ltd. (KOSDAQ:208710) Shares Could Introduce Price Risks After 49% Bounce

Biolog Device Co., Ltd. ( KOSDAQ:208710 ) shareholders would be excited to see that the share price has had a great...
Analysis Article Nov 14

Biolog Device Co., Ltd. (KOSDAQ:208710) Might Not Be As Mispriced As It Looks

It's not a stretch to say that Biolog Device Co., Ltd.'s ( KOSDAQ:208710 ) price-to-sales (or "P/S") ratio of 0.2x...
Analysis Article Jul 04

It's Down 26% But Biolog Device Co., Ltd. (KOSDAQ:208710) Could Be Riskier Than It Looks

Biolog Device Co., Ltd. ( KOSDAQ:208710 ) shareholders that were waiting for something to happen have been dealt a blow...
Analysis Article May 21

Does Biolog Device (KOSDAQ:208710) Have A Healthy Balance Sheet?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Analysis Article Mar 29

We Think Biolog Device (KOSDAQ:208710) Has A Fair Chunk Of Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Nov 25

Biolog Device (KOSDAQ:208710) Has A Somewhat Strained Balance Sheet

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Financial Position Analysis

Short Term Liabilities: A208710's short term assets (₩44.0B) exceed its short term liabilities (₩40.4B).

Long Term Liabilities: A208710's short term assets (₩44.0B) exceed its long term liabilities (₩1.4B).


Debt to Equity History and Analysis

Debt Level: A208710's net debt to equity ratio (19.8%) is considered satisfactory.

Reducing Debt: A208710's debt to equity ratio has reduced from 115.9% to 37.9% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: A208710 has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: A208710 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 29.9% each year


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/15 12:32
End of Day Share Price 2026/07/15 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Photon Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.